These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 27233291)
1. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures. Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291 [TBL] [Abstract][Full Text] [Related]
2. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. Drewitz M; Helbling M; Fried N; Bieri M; Moritz W; Lichtenberg J; Kelm JM Biotechnol J; 2011 Dec; 6(12):1488-96. PubMed ID: 22102438 [TBL] [Abstract][Full Text] [Related]
3. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening. Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871 [TBL] [Abstract][Full Text] [Related]
4. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions. Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887 [TBL] [Abstract][Full Text] [Related]
5. Reproducibility of Uniform Spheroid Formation in 384-Well Plates: The Effect of Medium Evaporation. Das V; Fürst T; Gurská S; Džubák P; Hajdúch M J Biomol Screen; 2016 Oct; 21(9):923-30. PubMed ID: 27226477 [TBL] [Abstract][Full Text] [Related]
6. High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing. Jun HR; Kang HJ; Ju SH; Kim JE; Jeon SY; Ku B; Lee JJ; Kim M; Kim MJ; Choi JJ; Noh JJ; Kim HS; Lee JW; Lee JK; Lee DW Biomaterials; 2023 May; 296():122087. PubMed ID: 36924663 [TBL] [Abstract][Full Text] [Related]
7. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids. Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088 [TBL] [Abstract][Full Text] [Related]
8. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping. Burkhart RA; Baker LA; Tiriac H Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724 [TBL] [Abstract][Full Text] [Related]
9. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids. Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999 [TBL] [Abstract][Full Text] [Related]
10. High-throughput screening in colorectal cancer tissue-originated spheroids. Kondo J; Ekawa T; Endo H; Yamazaki K; Tanaka N; Kukita Y; Okuyama H; Okami J; Imamura F; Ohue M; Kato K; Nomura T; Kohara A; Mori S; Dan S; Inoue M Cancer Sci; 2019 Jan; 110(1):345-355. PubMed ID: 30343529 [TBL] [Abstract][Full Text] [Related]
11. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device. LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110 [TBL] [Abstract][Full Text] [Related]
12. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids. Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028 [TBL] [Abstract][Full Text] [Related]
13. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems. Howes AL; Richardson RD; Finlay D; Vuori K PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711 [TBL] [Abstract][Full Text] [Related]
14. Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening? Eglen RM; Randle DH Assay Drug Dev Technol; 2015 Jun; 13(5):262-5. PubMed ID: 26121065 [TBL] [Abstract][Full Text] [Related]
15. Drug Sensitivity Assays of Human Cancer Organoid Cultures. Francies HE; Barthorpe A; McLaren-Douglas A; Barendt WJ; Garnett MJ Methods Mol Biol; 2019; 1576():339-351. PubMed ID: 27628132 [TBL] [Abstract][Full Text] [Related]
16. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates. Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502 [TBL] [Abstract][Full Text] [Related]
17. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer. Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096 [TBL] [Abstract][Full Text] [Related]
18. Assay establishment and validation of a high-throughput organoid-based drug screening platform. Li X; Fu G; Zhang L; Guan R; Tang P; Zhang J; Rao X; Chen S; Xu X; Zhou Y; Deng Y; Lv T; He X; Mo S; Mu P; Gao J; Hua G Stem Cell Res Ther; 2022 May; 13(1):219. PubMed ID: 35619149 [TBL] [Abstract][Full Text] [Related]
19. Fully Automated One-Step Production of Functional 3D Tumor Spheroids for High-Content Screening. Monjaret F; Fernandes M; Duchemin-Pelletier E; Argento A; Degot S; Young J J Lab Autom; 2016 Apr; 21(2):268-80. PubMed ID: 26385905 [TBL] [Abstract][Full Text] [Related]
20. Single and Combination Drug Screening with Aqueous Biphasic Tumor Spheroids. Shahi Thakuri P; Tavana H SLAS Discov; 2017 Jun; 22(5):507-515. PubMed ID: 28324660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]